Differential effects of divalent cations on elk prion protein fibril formation and stability

References

• Prusiner SB.. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216(4542):136–44. doi:10.1126/science.6801762
   PubMed Web of Science ®Google Scholar
• Prusiner SB. The prion diseases. Brain Pathol. 1998;8(3):499–513. doi:10.1111/j.1750-3639.1998.tb00171.x
   PubMed Web of Science ®Google Scholar
• Williams ES, Young S. Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis. 1980;16(1):89–98. doi:10.7589/0090-3558-16.1.89
   PubMed Web of Science ®Google Scholar
• Williams ES, Young S. Spongiform encephalopathy of Rocky Mountain elk. J Wildl Dis. 1982;18(4):465–71. doi:10.7589/0090-3558-18.4.465
   PubMed Web of Science ®Google Scholar
• Spraker TR, Miller MW, Williams ES, et al. Spongiform encephalopathy in free-ranging mule deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus) and Rocky Mountain elk (Cervus elaphus nelsoni) in northcentral Colorado. J Wildl Dis. 1997;33(1):1–6. doi:10.7589/0090-3558-33.1.1
   PubMed Web of Science ®Google Scholar
• Raymond GJ, Bossers A, Raymond LD, et al. Evidence of a molecular barrier limiting susceptibility of humans, cattle and sheep to chronic wasting disease. EMBO J. 2000;19(17):4425–30. doi:10.1093/emboj/19.17.4425
   PubMed Web of Science ®Google Scholar
• Kurt TD, Sigurdson CJ. Cross-species transmission of CWD prions. Prion. 2016;10(1):83–91. doi:10.1080/19336896.2015.1118603
   PubMed Web of Science ®Google Scholar
• Kurt TD, Telling GC, Zabel MD, et al. Trans-species amplification of PrP(CWD) and correlation with rigid loop 170N. Virology. 2009;387(1):235–43. doi:10.1016/j.virol.2009.02.025
   PubMed Web of Science ®Google Scholar
• Hwang S, Greenlee JJ, Nicholson EM. Use of bovine recombinant prion protein and real-time quaking-induced conversion to detect cattle transmissible mink encephalopathy prions and discriminate classical and atypical L- and H-Type bovine spongiform encephalopathy. PLoS One. 2017;12(2):e0172391. doi:10.1371/journal.pone.0172391
   PubMed Web of Science ®Google Scholar
• Moore SJ, Smith JD, Greenlee MH, et al. Comparison of Two US Sheep Scrapie Isolates Supports Identification as Separate Strains. Vet Pathol. 2016;53(6):1187–1196. doi:10.1177/0300985816629712
   PubMed Web of Science ®Google Scholar
• Moore SJ, West Greenlee MH, Smith JD, et al. A Comparison of Classical and H-Type Bovine Spongiform Encephalopathy Associated with E211K Prion Protein Polymorphism in Wild-Type and EK211 Cattle Following Intracranial Inoculation. Front Vet Sci. 2016;3:78. doi:10.3389/fvets.2016.00078
   PubMedGoogle Scholar
• Hamir AN, Gidlewski T, Spraker TR, et al. Preliminary observations of genetic susceptibility of elk (Cervus elaphus nelsoni) to chronic wasting disease by experimental oral inoculation. J Vet Diagn Invest. 2006;18(1):110–4. doi:10.1177/104063870601800118
   PubMed Web of Science ®Google Scholar
• O'Rourke KI, Spraker TR, Zhuang D, et al. Elk with a long incubation prion disease phenotype have a unique PrPd profile. Neuroreport. 2007;18(18):1935–8. doi:10.1097/WNR.0b013e3282f1ca2f
   PubMed Web of Science ®Google Scholar
• Asante EA, Linehan JM, Gowland I, et al. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci U S A. 2006;103(28):10759–64. doi:10.1073/pnas.0604292103
   PubMed Web of Science ®Google Scholar
• Wadsworth JD, Asante EA, Desbruslais M, et al. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science. 2004;306(5702):1793–6. doi:10.1126/science.1103932
   PubMed Web of Science ®Google Scholar
• Meade-White K, Race B, Trifilo M, et al. Resistance to chronic wasting disease in transgenic mice expressing a naturally occurring allelic variant of deer prion protein. J Virol. 2007;81(9):4533–9. doi:10.1128/JVI.02762-06
   PubMed Web of Science ®Google Scholar
• Mitchell GB, Sigurdson CJ, O'Rourke KI, et al. Experimental oral transmission of chronic wasting disease to reindeer (Rangifer tarandus tarandus). PLoS One. 2012;7(6):e39055. doi:10.1371/journal.pone.0039055
   PubMed Web of Science ®Google Scholar
• USGS National Wildlife Health Center. Map of chronic wasting disease in North America. <http://www.nwhc.usgs.gov/disease_information/chronic_wasting_disease/>.
   Google Scholar
• Lee YH, Sohn HJ, Kim MJ, et al. Strain characterization of the Korean CWD cases in 2001 and 2004; J Vet Med Sci. 2013;75(1):95–8. doi:10.1292/jvms.12-0077
   Google Scholar
• Benestad SL, Mitchell G, Simmons M, et al. First case of chronic wasting disease in Europe in a Norwegian free-ranging reindeer. Vet Res. 2016;47(1):88. doi:10.1186/s13567-016-0375-4
   PubMed Web of Science ®Google Scholar
• Stockel J, Safar J, Wallace AC, et al. Prion protein selectively binds copper(II) ions. Biochemistry. 1998;37(20):7185–93. doi:10.1021/bi972827k
   PubMed Web of Science ®Google Scholar
• Walter ED, Stevens DJ, Spevacek AR, et al. Copper binding extrinsic to the octarepeat region in the prion protein. Curr Protein Pept Sci. 2009;10(5):529–35. doi:10.2174/138920309789352056
   PubMed Web of Science ®Google Scholar
• Walter ED, Stevens DJ, Visconte MP, et al. The prion protein is a combined zinc and copper binding protein: Zn2+ alters the distribution of Cu2+ coordination modes. J Am Chem Soc. 2007;129(50):15440–1. doi:10.1021/ja077146j
   PubMed Web of Science ®Google Scholar
• Nichols TA, Spraker TR, Gidlewski T, et al. Dietary magnesium and copper affect survival time and neuroinflammation in chronic wasting disease. Prion. 2016;10(3):228–50. doi:10.1080/19336896.2016.1181249
   PubMed Web of Science ®Google Scholar
• Bocharova OV, Breydo L, Salnikov VV, et al. Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils. Biochemistry. 2005;44(18):6776–87. doi:10.1021/bi050251q
   PubMed Web of Science ®Google Scholar
• Greenfield NJ. Using circular dichroism collected as a function of temperature to determine the thermodynamics of protein unfolding and binding interactions. Nat Protoc. 2006;1(6):2527–35. doi:10.1038/nprot.2006.204
   PubMed Web of Science ®Google Scholar
• Santoro MM, Bolen DW. Unfolding free energy changes determined by the linear extrapolation method. 1 Unfolding of phenylmethanesulfonyl alpha-chymotrypsin using different denaturants Biochemistry. 1988;27(21):8063–8.
   Google Scholar
• Bocharova OV, Breydo L, Parfenov AS, et al. In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc). J Mol Biol. 2005;346(2):645–59. doi:10.1016/j.jmb.2004.11.068
   PubMed Web of Science ®Google Scholar
• Brown DR, Hafiz F, Glasssmith LL, et al. Consequences of manganese replacement of copper for prion protein function and proteinase resistance. EMBO J. 2000;19(6):1180–6. doi:10.1093/emboj/19.6.1180
   PubMed Web of Science ®Google Scholar
• Greenfield NJ. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc. 2006;1(6):2876–90. doi:10.1038/nprot.2006.202
   PubMed Web of Science ®Google Scholar
• Greenfield NJ. Determination of the folding of proteins as a function of denaturants, osmolytes or ligands using circular dichroism. Nat Protoc. 2006;1(6):2733–41.
   PubMed Web of Science ®Google Scholar
• Johnson WC, Jr.. Protein secondary structure and circular dichroism: A practical guide. Proteins. 1990;7(3):205–14. doi:10.1002/prot.340070302
   PubMed Web of Science ®Google Scholar
• Greenfield NJ.. Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. Anal Biochem. 1996;235(1):1–10. doi:10.1006/abio.1996.0084
   PubMed Web of Science ®Google Scholar
• Wilham JM, Orru CD, Bessen RA, et al. Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog. 2010;6(12):e1001217. doi:10.1371/journal.ppat.1001217
   PubMed Web of Science ®Google Scholar
• Vascellari S, Orru CD, Hughson AG, et al. Prion seeding activities of mouse scrapie strains with divergent PrPSc protease sensitivities and amyloid plaque content using RT-QuIC and eQuIC. PLoS One. 2012;7(11):e48969. doi:10.1371/journal.pone.0048969
   PubMed Web of Science ®Google Scholar
• Biancalana M, Koide S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim Biophys Acta. 2010;1804(7):1405–12. doi:10.1016/j.bbapap.2010.04.001
   PubMed Web of Science ®Google Scholar
• Vrentas CE, Onstot S, Nicholson EM. A comparative analysis of rapid methods for purification and refolding of recombinant bovine prion protein. Protein Expr Purif. 2012;82(2):380–8. doi:10.1016/j.pep.2012.02.008
   PubMed Web of Science ®Google Scholar
• Zhu F, Davies P, Thompsett AR, et al. Raman optical activity and circular dichroism reveal dramatic differences in the influence of divalent copper and manganese ions on prion protein folding. Biochemistry. 2008;47(8):2510–7. doi:10.1021/bi7022893
   PubMed Web of Science ®Google Scholar
• Gossert AD, Bonjour S, Lysek DA, et al. Prion protein NMR structures of elk and of mouse/elk hybrids. Proc Natl Acad Sci U S A. 2005;102(3):646–50. doi:10.1073/pnas.0409008102
   PubMed Web of Science ®Google Scholar
• Spevacek AR, Evans EG, Miller JL, et al. Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface. Structure. 2013;21(2):236–46. doi:10.1016/j.str.2012.12.002
   PubMed Web of Science ®Google Scholar
• Evans EG, Pushie MJ, Markham KA, et al. Interaction between Prion Protein's Copper-Bound Octarepeat Domain and a Charged C-Terminal Pocket Suggests a Mechanism for N-Terminal Regulation. Structure. 2016;24(7):1057–67. doi:10.1016/j.str.2016.04.017
   PubMed Web of Science ®Google Scholar
• Sharma A, Bruce KL, Chen B, et al. Contributions of the Prion Protein Sequence, Strain, and Environment to the Species Barrier. J Biol Chem. 2016;291(3):1277–88. doi:10.1074/jbc.M115.684100
   PubMed Web of Science ®Google Scholar
• Gonzalez-Iglesias R, Pajares MA, Ocal C, et al. Prion protein interaction with glycosaminoglycan occurs with the formation of oligomeric complexes stabilized by Cu(II) bridges. J Mol Biol. 2002;319(2):527–40. doi:10.1016/S0022-2836(02)00341-8
   PubMed Web of Science ®Google Scholar
• Miller Y, Ma B, Nussinov R. Zinc ions promote Alzheimer Abeta aggregation via population shift of polymorphic states. Proc Natl Acad Sci U S A. 2010;107(21):9490–5. doi:10.1073/pnas.0913114107
   PubMed Web of Science ®Google Scholar
• Miller Y. MB, Nussinov R.. Metal binding sites in amyloid oligomers: Complexes and mechanisms. Coordination Chemistry Reviews. 2012;256(19-20):7. doi:10.1016/j.ccr.2011.12.022
   Web of Science ®Google Scholar
• Parthasarathy S, Long F, Miller Y, et al. Molecular-level examination of Cu2+ binding structure for amyloid fibrils of 40-residue Alzheimer's beta by solid-state NMR spectroscopy. J Am Chem Soc. 2011;133(10):3390–400. doi:10.1021/ja1072178
   PubMed Web of Science ®Google Scholar
• Swint L, Robertson AD. Thermodynamics of unfolding for turkey ovomucoid third domain: thermal and chemical denaturation. Protein Sci. 1993;2(12):2037–49. doi:10.1002/pro.5560021205
   PubMed Web of Science ®Google Scholar